Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>
Guardat en:
| Autor principal: | |
|---|---|
| Altres autors: | , , , , , , , , , , , , , , |
| Publicat: |
2025
|
| Matèries: | |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| _version_ | 1849927632305520640 |
|---|---|
| author | Sofie H. Tolmeijer (15313251) |
| author2 | Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| author2_role | author author author author author author author author author author author author author author author |
| author_facet | Sofie H. Tolmeijer (15313251) Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sofie H. Tolmeijer (15313251) Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| dc.date.none.fl_str_mv | 2025-11-25T13:28:35Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709275 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Early_On-treatment_Changes_in_Circulating_Tumor_DNA_Fraction_and_Response_to_Enzalutamide_or_Abiraterone_in_Metastatic_Castration-Resistant_Prostate_Cancer/30709275 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |
| dc.title.none.fl_str_mv | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Multivariable Cox proportional hazards models for time to progression and time to death</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_e5c9b2437860079ab11a05f282205a16 |
| identifier_str_mv | 10.1158/1078-0432.30709275 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709275 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H. Tolmeijer (15313251)Emmy Boerrigter (15313254)Takayuki Sumiyoshi (15034119)Edmond M. Kwan (15313257)Sarah W.S. Ng (14960841)Matti Annala (15313260)Gráinne Donnellan (15313263)Cameron Herberts (14960820)Guillemette E. Benoist (15313266)Paul Hamberg (15313269)Diederik M. Somford (15035198)Inge M. van Oort (15035171)Jack A. Schalken (15313272)Niven Mehra (15011036)Nielka P. van Erp (15313275)Alexander W. Wyatt (14960922)CancerCancer Detection and DiagnosisMethods and TechnologyBiomarkersCirculating tumor cells/DNA/exosomesGenitourinary CancersProstate cancerLiquid Biopsy<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>2025-11-25T13:28:35ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709275https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Early_On-treatment_Changes_in_Circulating_Tumor_DNA_Fraction_and_Response_to_Enzalutamide_or_Abiraterone_in_Metastatic_Castration-Resistant_Prostate_Cancer/30709275CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307092752025-11-25T13:28:35Z |
| spellingShingle | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer Sofie H. Tolmeijer (15313251) Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |
| status_str | publishedVersion |
| title | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_full | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_fullStr | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_full_unstemmed | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_short | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_sort | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| topic | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |